Without tocilizumab we found these results: https://t.co/rICoC1F49Q #ICU #IDtwitter, #antibioticstewardship
@gpollara @dr_mattmorgan @charlot_summers @RostronTony Interesting zo read this. We got a different impression from our data (nor CRP nor PCT worked anymore for diagnosis after #Tocilizumab, different to without: https://t.co/rICoC1F49Q). Have to double ch
Kinetics and predictive value of procalcitonin and C-reactive protein in #COVID19 patients. https://t.co/ZiPDonT1fa https://t.co/EUHZC0zFDr
@ICU_Management @thermofisher Maybe this one is interesting to discuss. Let us know what you think about it, if you like. @jeroenschouten3 @ICresearch_Rumc @radboudumc https://t.co/PvuIhWhckX
@ForniLuiG v little in literature on PCT & COVID - one small dutch study shows cut 1 had 93% PPV & <0.25 NPV 81% https://t.co/Qwf7HWJDIb
@Manoj_Wickram @alexfwarren @load_dependent Maybe this one of interest regarding #COVIDー19 https://t.co/rICoC1F49Q
@maureviv @load_dependent https://t.co/rICoC1F49Q Maybe this one helps. #covid19
@natalevaz @load_dependent https://t.co/rICoC1F49Q Maybe this one helps a little. #covid19
RT @yoncabulutmd: Procalcitonin CRP Biomarkers for antimicrobial stewardship in #COVID19 Thx @Alpkorki @destmauricemd #PedsICU @PIPS…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @augustoraulhm: Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Conse…
Existe un abuso sin sentido en el uso de antibióticos como parte del tratamiento estándar de pacientes con COVID. Consecuencia: Altísima cantidad de gérmenes MR, que agregan mortalidad y tiempo en ventilación en la UCI.
Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? | Critical Care | Full Text https://t.co/cjedGHMS21
RT @yoncabulutmd: Procalcitonin CRP Biomarkers for antimicrobial stewardship in #COVID19 Thx @Alpkorki @destmauricemd #PedsICU @PIPS…
RT @Crit_Care: #CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/Qoa…
RT @yoncabulutmd: Procalcitonin CRP Biomarkers for antimicrobial stewardship in #COVID19 Thx @Alpkorki @destmauricemd #PedsICU @PIPS…
RT @yoncabulutmd: Procalcitonin CRP Biomarkers for antimicrobial stewardship in #COVID19 Thx @Alpkorki @destmauricemd #PedsICU @PIPS…
Procalcitonin CRP Biomarkers for antimicrobial stewardship in #COVID19 Thx @Alpkorki @destmauricemd #PedsICU @PIPSQC @sgdambrauskas @MiguelrrMD @areinamo21 @VSLanziotti @hakanakelma https://t.co/qrWpMT2op3
#CritCare #OpenAccess #COVID_19: use of #biomarkers for secondary #infections reduces #antibiotic overuse https://t.co/QoamZ31pZx #FOAMed #FOAMcc #BMC #ICU #Intensive_care #coronavirus #pandemics #bacteria #antimicrobial_resistance@jlvincen">@jlvincen?src=hashtag_click">#antimicrobial_resistance@jlvincen @ISICEM htt
#Biomarkers to predict co- and secondary #infection in #ICU in #COVID19 Low #PCT—> Empirical antibiotic therapy should probably not be started —> Later on serial PCTs may help identify/ rule out bacterial infection —> #CRP difficult to use as disc
RT @CIDRAP_ASP: In the literature from @BioMedCentral Critical Care: "Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 t…
RT @horstie: guess this one is also something for #medtwitter #foamcc #foamecmo #IDtwitter and friends...
I have been critical of pricalcitonin in the past. Perhaps it's time to reconsider. Could be a useful tool in this pandemic: https://t.co/zchHqry3z5
RT @horstie: Thanks for sharing. To us this was a useful piece of information indeed. #IDtwitter #AMS #ICU #COVID19 https://t.co/BkdGdRqY6e
Thanks for sharing. To us this was a useful piece of information indeed. #IDtwitter #AMS #ICU #COVID19
In the literature from @BioMedCentral Critical Care: "Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times" (7/7) https://t.co/gGt8eQ9hZn
guess this one is also something for #medtwitter #foamcc #foamecmo #IDtwitter and friends...
How to use #CRP and #PCT in #COVID19: #Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? https://t.co/bHMPH14ECK (#openaccess) @ICresearch_Rumc @jeroenschouten3 @radboudumc @radboudumc_weet @crit_care #ICU https://t.co/kE7C2kkTJ